Heron Therapeutics (HRTX) Competitors $2.18 -0.04 (-1.80%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$2.18 +0.00 (+0.23%) As of 07/11/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HRTX vs. TVTX, CVAC, PAHC, ABCL, CALT, HROW, WVE, AMPH, GPCR, and COGTShould you be buying Heron Therapeutics stock or one of its competitors? The main competitors of Heron Therapeutics include Travere Therapeutics (TVTX), CureVac (CVAC), Phibro Animal Health (PAHC), AbCellera Biologics (ABCL), Calliditas Therapeutics AB (publ) (CALT), Harrow (HROW), WAVE Life Sciences (WVE), Amphastar Pharmaceuticals (AMPH), Structure Therapeutics (GPCR), and Cogent Biosciences (COGT). These companies are all part of the "pharmaceutical products" industry. Heron Therapeutics vs. Its Competitors Travere Therapeutics CureVac Phibro Animal Health AbCellera Biologics Calliditas Therapeutics AB (publ) Harrow WAVE Life Sciences Amphastar Pharmaceuticals Structure Therapeutics Cogent Biosciences Heron Therapeutics (NASDAQ:HRTX) and Travere Therapeutics (NASDAQ:TVTX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, dividends, institutional ownership, analyst recommendations, earnings and valuation. Does the media favor HRTX or TVTX? In the previous week, Travere Therapeutics had 1 more articles in the media than Heron Therapeutics. MarketBeat recorded 4 mentions for Travere Therapeutics and 3 mentions for Heron Therapeutics. Travere Therapeutics' average media sentiment score of 1.04 beat Heron Therapeutics' score of 0.91 indicating that Travere Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heron Therapeutics 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Travere Therapeutics 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate HRTX or TVTX? Heron Therapeutics presently has a consensus price target of $5.00, indicating a potential upside of 129.36%. Travere Therapeutics has a consensus price target of $32.14, indicating a potential upside of 95.16%. Given Heron Therapeutics' stronger consensus rating and higher possible upside, equities analysts clearly believe Heron Therapeutics is more favorable than Travere Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Travere Therapeutics 0 Sell rating(s) 2 Hold rating(s) 13 Buy rating(s) 0 Strong Buy rating(s) 2.87 Which has preferable valuation and earnings, HRTX or TVTX? Heron Therapeutics has higher earnings, but lower revenue than Travere Therapeutics. Heron Therapeutics is trading at a lower price-to-earnings ratio than Travere Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeron Therapeutics$144.29M2.30-$13.58M-$0.06-36.33Travere Therapeutics$233.18M6.27-$321.55M-$2.81-5.86 Is HRTX or TVTX more profitable? Heron Therapeutics has a net margin of -5.24% compared to Travere Therapeutics' net margin of -82.88%. Heron Therapeutics' return on equity of 0.00% beat Travere Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Heron Therapeutics-5.24% N/A -3.43% Travere Therapeutics -82.88%-1,179.73%-41.10% Which has more risk & volatility, HRTX or TVTX? Heron Therapeutics has a beta of 1.18, indicating that its stock price is 18% more volatile than the S&P 500. Comparatively, Travere Therapeutics has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Do insiders and institutionals believe in HRTX or TVTX? 80.0% of Heron Therapeutics shares are held by institutional investors. 5.9% of Heron Therapeutics shares are held by insiders. Comparatively, 4.2% of Travere Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryHeron Therapeutics beats Travere Therapeutics on 10 of the 16 factors compared between the two stocks. Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRTX vs. The Competition Export to ExcelMetricHeron TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$332.59M$2.42B$5.56B$9.11BDividend YieldN/A1.79%5.06%4.01%P/E Ratio-36.339.4228.2620.26Price / Sales2.30732.10437.10166.10Price / CashN/A164.4637.1257.67Price / Book-9.914.608.045.49Net Income-$13.58M$31.26M$3.19B$250.45M7 Day Performance0.69%4.80%3.62%4.79%1 Month Performance12.95%8.17%5.98%9.59%1 Year Performance-32.72%-3.88%29.39%16.41% Heron Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRTXHeron Therapeutics3.6816 of 5 stars$2.18-1.8%$5.00+129.4%-32.7%$332.59M$144.29M-36.33300TVTXTravere Therapeutics3.704 of 5 stars$14.60-2.7%$32.14+120.2%+68.1%$1.30B$273.53M-5.20460CVACCureVac4.6882 of 5 stars$5.41-0.7%$6.83+26.3%+67.5%$1.21B$523.70M5.88880Positive NewsPAHCPhibro Animal Health4.0475 of 5 stars$29.90+6.8%$24.40-18.4%+76.2%$1.21B$1.02B38.331,940High Trading VolumeABCLAbCellera Biologics2.129 of 5 stars$4.03+6.1%$7.50+86.1%+28.5%$1.20B$28.83M-7.20500News CoverageAnalyst RevisionHigh Trading VolumeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180HROWHarrow2.1909 of 5 stars$31.36-1.2%$61.40+95.8%+47.9%$1.15B$199.61M-56.00180News CoverageAnalyst ForecastWVEWAVE Life Sciences4.5468 of 5 stars$7.06+1.6%$20.50+190.4%+37.0%$1.10B$108.30M-8.40240AMPHAmphastar Pharmaceuticals4.3368 of 5 stars$22.86-1.5%$32.33+41.4%-44.0%$1.08B$731.97M8.282,028GPCRStructure Therapeutics2.6114 of 5 stars$18.73-8.0%$76.17+306.7%-56.7%$1.07BN/A-21.53136COGTCogent Biosciences3.027 of 5 stars$9.35+23.4%$16.33+74.7%+18.4%$1.06BN/A-5.0880Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume Related Companies and Tools Related Companies Travere Therapeutics Competitors CureVac Competitors Phibro Animal Health Competitors AbCellera Biologics Competitors Calliditas Therapeutics AB (publ) Competitors Harrow Competitors WAVE Life Sciences Competitors Amphastar Pharmaceuticals Competitors Structure Therapeutics Competitors Cogent Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HRTX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTX Stock Alerts